Plasma CAF22 Levels as a Useful Predictor of Muscle Health in Patients with Chronic Obstructive Pulmonary Disease

• Published in: Biology (Basel, Switzerland) Vol. 9; no. 7; p. 166
• Main Authors: Qaisar, Rizwan, Karim, Asima, Muhammad, Tahir
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-07-2020; MDPI
• Subjects: Age; Agrin; Atrophy; Biological markers; Biomarkers; Blood plasma; Chronic obstructive pulmonary disease; COPD; Diagnosis; Disease; Health aspects; Heat shock proteins; Lung diseases; Lung diseases, Obstructive; Lungs; Muscles; muscular atrophy; Musculoskeletal system; Obstructive lung disease; Physiological aspects; Plasma; Quality of life; Sarcopenia; Skeletal muscle; Spirometry; United Arab Emirates; United States > US
• ISSN: 2079-7737; 2079-7737
• DOI: 10.3390/biology9070166

Skeletal muscle dysfunction and reduced physical capacity are characteristic features of chronic obstructive pulmonary disease (COPD). However, the search for a reliable biomarker to assess muscle health in CODP remains elusive. We analyzed the course of hand-grip strength (HGS) and appendicular skeletal mass index (ASMI) in COPD in relation to spirometry decline and plasma extracellular heat shock protein-72 (eHSP72) and c-terminal fragment of agrin-22 (CAF22) levels. We evaluated male, 62–73 years old patients of COPD (N = 265) and healthy controls (N = 252) at baseline and after 12 and 24 months for plasma biomarkers, spirometry and HGS measurements. HGS declined significantly over time and plasma CAF22, but not eHSP72 levels, had a significant negative association with HGS and ASMI in COPD. Plasma CAF22 also had an association with walking speed and daily steps count in advanced COPD. Lower ASMI was associated with reduced HGS at all time-point. Narrow age-span of the study cohort and exclusion of lower-limb muscles from the analysis are limitations of this study. Taken together, we report that the plasma CAF22 may be a useful tool to assess muscle weakness and atrophy in COPD patients.